Inhibrx Biosciences, Inc. (INBX) — Cash Flow Quality Index
Inhibrx Biosciences, Inc. (INBX) has a Cash Flow Quality Index of -0.03x as of June 2024. Operating cash flow of $-57.36 Million is below net income of $1.83 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Inhibrx Biosciences, Inc. operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Inhibrx Biosciences, Inc. Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Inhibrx Biosciences, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Inhibrx Biosciences, Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Quality Index for Inhibrx Biosciences, Inc. (2024–2024)
Year-by-year earnings quality comparison for Inhibrx Biosciences, Inc.. For live market cap and the full company financial profile, see market value of Inhibrx Biosciences, Inc..
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.12x | $-194.41 Million | $1.69 Billion | — |